Clinical Utility of Pre-Therapeutic [18F]FDG PET/CT Imaging for Predicting Outcomes in Breast Cancer.

Najid, Sophia; Seban, Romain-David; Champion, Laurence; De Moura, Alexandre; Sebbag, Clara; Salaün, Hélène; Cabel, Luc; Bonneau, Claire

Najid, Sophia; Seban, Romain-David; Champion, Laurence; De Moura, Alexandre; Sebbag, Clara; Salaün, Hélène; Cabel, Luc; Bonneau, Claire.

Afiliação

Najid S; Institut Curie, Inserm U900, 92210 Saint-Cloud, France.
Seban RD; Department of Nuclear Medicine, Institut Curie, 92210 Saint-Cloud, France.
Champion L; Department of Nuclear Medicine, Institut Curie, 92210 Saint-Cloud, France.
De Moura A; Department of Medical Oncology, Institut Curie, PSL Research University, 75005 Paris, France.
Sebbag C; UVSQ, Paris Saclay University, 92210 Saint-Cloud, France.
Salaün H; Department of Medical Oncology, Institut Curie, PSL Research University, 75005 Paris, France.
Cabel L; UVSQ, Paris Saclay University, 92210 Saint-Cloud, France.
Bonneau C; Department of Medical Oncology, Institut Curie, PSL Research University, 75005 Paris, France.

J Clin Med ; 12(17)2023 Aug 24.

Article em En | MEDLINE | ID: mdl-37685551

Palavras-chave

PET/CT imaging; breast cancer; neoadjuvant chemotherapy; pathological complete response; total metabolic tumor volume

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Clin Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google